Page last updated: 2024-09-03

dopamine 3-o-sulfate and Parkinson Disease

dopamine 3-o-sulfate has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, T; Mizutani, Y; Nabeshima, T; Ogawa, M; Okada, Y1
Eichinger, K; Fuchs, G; Jellinger, K; Kienzl, E; Kuhn, W; Laux, G; Riederer, P; Sofic, E1

Other Studies

2 other study(ies) available for dopamine 3-o-sulfate and Parkinson Disease

ArticleYear
Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients.
    Biological & pharmaceutical bulletin, 1995, Volume: 18, Issue:12

    Topics: Administration, Oral; Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Models, Biological; Parkinson Disease

1995
Urinary dopamine sulfate: regulations and significance in neurological disorders.
    Journal of neural transmission. Supplementum, 1990, Volume: 32

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Dopamine; Female; Humans; Male; Middle Aged; Nervous System Diseases; Parkinson Disease

1990